G 209 (Moexipril 7.5 mg)

Pill with imprint G 209 is Purple, Round and has been identified as Moexipril hydrochloride 7.5 mg. It is supplied by Glenmark Generics Inc..

Moexipril is used in the treatment of diabetic kidney disease; left ventricular dysfunction; heart attack; heart failure; high blood pressure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 209

Moexipril hydrochloride

Imprint:

G 209

Strength:

7.5 mg

Color:

Purple

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin Converting Enzyme Inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Glenmark Generics Inc.

Inactive Ingredients:

crospovidone
lactose monohydrate
magnesium oxide
magnesium stearate
povidone
hydroxypropyl cellulose (type h)
titanium dioxide
polyethylene glycol 6000
ferric oxide red
ferrosoferric oxide
hypromelloses
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.